---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-21-000027"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2021-08-09T23:59:59+00:00"
generated_at: "2026-06-29T19:40:48.149556+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ICU Medical wins arbitration; Pfizer not entitled to up to $225M earn-out from 2017 Hospira deal

## Summary
- Arbitrator ruled on August 7, 2021 that performance targets for HIS earn-out liability were not met.
- Pfizer disputed ICU Medical's determination that the $191.3M to $225.0M earn-out was not payable.
- Pfizer received no payment in connection with the earn-out liability under the Restated Purchase Agreement.
- The dispute arose from the January 2017 acquisition of Pfizer's Hospira Infusion Systems business.

## SEC filing metadata
- accession: 0000883984-21-000027
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2021-08-09T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398421000027/0000883984-21-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398421000027/icui-20210807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-21-000027
- JSON: https://secwatch.observer/filing/0000883984-21-000027.json
- Plain text: https://secwatch.observer/filing/0000883984-21-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.